![CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram](https://www.researchgate.net/publication/318847012/figure/fig2/AS:631650916511761@1527608722402/CA15-3-tumor-marker-level-over-the-course-of-the-patients-treatment-Solid-line-CA15-3.png)
CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer](https://www.spandidos-publications.com/article_images/ol/16/4/ol-16-04-4679-g00.jpg)
Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/3-Table2-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram](https://www.researchgate.net/publication/329615156/figure/fig2/AS:703368083275776@1544707427023/serum-Ca-15-3-behavior-during-postoperative-follow-up-of-patient-2-Abbreviations-Bs.png)
serum Ca 15-3 behavior during postoperative follow-up of patient 2.... | Download Scientific Diagram
![Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine](https://www.futuremedicine.com/cms/10.2217/bmm-2016-0142/asset/images/medium/figure2.gif)
Paradox CA 15–3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series | Biomarkers in Medicine
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig2_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![Observed changes in CA 15-3 levels in patients with de novo disease... | Download Scientific Diagram Observed changes in CA 15-3 levels in patients with de novo disease... | Download Scientific Diagram](https://www.researchgate.net/profile/Christoph-Zielinski/publication/7216454/figure/fig3/AS:216476322668550@1428623385090/Observed-changes-in-CA-15-3-levels-in-patients-3-months-prior-to-secondary-progression_Q320.jpg)
Observed changes in CA 15-3 levels in patients with de novo disease... | Download Scientific Diagram
![Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4244574818b6181db84800ea19173a80fa71094b/2-TableII-1.png)